1. Home
  2. Analysis
  3. Diphen
  4. Baqsimi

Diphen and Baqsimi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diphen (diphenhydramine hydrochloride) and Baqsimi (glucagon). Common drug interactions include arthralgia among females and hyperglycaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Diphen and Baqsimi. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Diphen?

Diphen has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 115,429 Diphen users. Check the latest studies of Diphen.

What is Baqsimi?

Baqsimi has active ingredients of glucagon. eHealthMe is studying from 493 Baqsimi users. Check the latest studies of Baqsimi.

On Nov, 08, 2025

11 people who take Diphen and Baqsimi together, and have interactions are studied.

Diphen and Baqsimi drug interactions.

What are the common drug interactions of Diphen and Baqsimi, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Respiratory tract infection
  3. Upper limb fracture
  4. Dizziness
  5. Headache (pain in head)
  6. Pain
  7. Skin infection
  8. Urinary tract infection
  9. Wound
  10. Wound haemorrhage (bleeding wound)

male:

  1. Hyperglycaemia (high blood sugar)

What are the common drug interactions of Diphen and Baqsimi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Hyperglycaemia (high blood sugar)

20-29:

n/a

30-39:

  1. Lumbar puncture
  2. Weight increased

40-49:

  1. Abdominal pain upper
  2. Blood urine present
  3. Constipation
  4. Dizziness
  5. Fungal infection
  6. Headache (pain in head)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Migraine (headache)
  9. Nasal ulcer (ulcer of nose)
  10. Nausea (feeling of having an urge to vomit)

50-59:

  1. Arthralgia (joint pain)
  2. Contusion (a type of hematoma of tissue in which capillaries)
  3. Upper limb fracture
  4. Skin infection
  5. Wound
  6. Wound haemorrhage (bleeding wound)
  7. Dizziness
  8. Fatigue (feeling of tiredness)
  9. Headache (pain in head)
  10. Hepatic enzyme increased

60+:

n/a

What are the existing conditions these people have? *

  1. Myotonia (a state of hyperexcitability in muscle fibres in which a voluntary contraction): 1 person, 9.09%
  2. Impaired Gastric Emptying: 1 person, 9.09%
  3. Immunodeficiency Common Variable: 1 person, 9.09%
  4. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 9.09%
  5. Autonomic Neuropathy (malfunction of the autonomic nervous system (ans)): 1 person, 9.09%
  6. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Diphen and Baqsimi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diphen and Baqsimi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diphen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Baqsimi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diphen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Baqsimi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diphenhydramine hydrochloride and glucagon (the active ingredients of Diphen and Baqsimi, respectively), and Diphen and Baqsimi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2025 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.